down arrow

Orchid Pharma

9
Strong Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE191A01027
  • NSEID: ORCHPHARMA
  • BSEID: 524372
INR
727.95
22.95 (3.26%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 43.35 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Rs cr
Consolidated - Profit And Loss Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
No of Months
12
12
12
12
12
12
Operating Income
819.00
665.00
559.00
450.00
483.00
599.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
819.00
665.00
559.00
450.00
483.00
599.00
Expenditure (Ex Depriciation)
Stock Adjustments
-43.00
-21.00
-27.00
-17.00
-18.00
26.00
Raw Materials Consumed
528.00
406.00
340.00
245.00
221.00
263.00
Power & Fuel Cost
62.00
61.00
52.00
39.00
47.00
48.00
Employee Cost
69.00
65.00
63.00
67.00
74.00
82.00
Operating Expenses
32.00
29.00
26.00
24.00
41.00
41.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
23.00
14.00
22.00
13.00
8.00
10.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
5.00
6.00
7.00
3.00
22.00
94.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
708.00
581.00
504.00
399.00
453.00
611.00
Operating Profit (PBDIT) excl Other Income
111.00
84.00
54.00
50.00
30.00
-11.00
Other Income
30.00
19.00
9.00
15.00
24.00
16.00
Operating Profit (PBDIT)
141.00
103.00
63.00
65.00
54.00
5.00
Interest
16.00
32.00
33.00
52.00
6.00
6.00
Profit before Depriciation and Tax
125.00
70.00
30.00
13.00
48.00
-1.00
Depreciation
33.00
54.00
87.00
108.00
117.00
129.00
Profit Before Taxation & Exceptional Items
91.00
16.00
-56.00
-95.00
-69.00
-131.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
91.00
55.00
-56.00
-95.00
-69.00
69.00
Provision for Tax
-3.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
95.00
55.00
-56.00
-95.00
-69.00
69.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
-2,268.00
-2,314.00
-2,313.00
-2,197.00
-1,869.00
-1,940.00
Profit Available for appropriations
-2,176.00
-2,261.00
-2,374.00
-2,293.00
-1,939.00
-1,870.00
Appropriations
-2,176.00
-2,261.00
-2,374.00
-2,293.00
-1,939.00
-1,870.00
Equity Dividend (%)
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Earnings Per Share
19.06
11.35
-0.48
-28.55
-14.75
7.80
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2024 is 23.05% vs 19.00% in Mar 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2024 is 31.75% vs 54.45% in Mar 2023

stock-summary

Interest

YoY Growth in year ended Mar 2024 is -49.14% vs -1.66% in Mar 2023

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2024 is 72.07% vs 197.10% in Mar 2023

Compare Profit and Loss Results of Orchid Pharma
Markets Mojo
Figures in Rs cr
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
819.00
10,334.00
-9,515.00
-92.07%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
819.00
10,334.00
-9,515.00
-92.07%
Expenditure (Ex Depriciation)
Stock Adjustments
-43.00
-94.00
51.00
54.26%
Raw Materials Consumed
528.00
3,263.00
-2,735.00
-83.82%
Power & Fuel Cost
62.00
129.00
-67.00
-51.94%
Employee Cost
69.00
2,274.00
-2,205.00
-96.97%
Operating Expenses
32.00
210.00
-178.00
-84.76%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
23.00
928.00
-905.00
-97.52%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
5.00
134.00
-129.00
-96.27%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
708.00
7,798.00
-7,090.00
-90.92%
Operating Profit (PBDIT) excl Other Income
111.00
2,536.00
-2,425.00
-95.62%
Other Income
30.00
280.00
-250.00
-89.29%
Operating Profit (PBDIT)
141.00
2,817.00
-2,676.00
-94.99%
Interest
16.00
35.00
-19.00
-54.29%
Profit before Depriciation and Tax
125.00
2,782.00
-2,657.00
-95.51%
Depreciation
33.00
398.00
-365.00
-91.71%
Profit Before Taxation & Exceptional Items
91.00
2,384.00
-2,293.00
-96.18%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
91.00
2,399.00
-2,308.00
-96.21%
Provision for Tax
-3.00
457.00
-460.00
-100.66%
Profit After Tax
95.00
1,926.00
-1,831.00
-95.07%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
-2,268.00
8,012.00
-10,280.00
-128.31%
Profit Available for appropriations
-2,176.00
9,925.00
-12,101.00
-121.92%
Appropriations
-2,176.00
9,925.00
-12,101.00
-121.92%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
19.06
47.75
-28.69
-60.08%
Profit And Loss - Net Sales
Net Sales 819.37 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 23.05% vs 19.00% in Mar 2023

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 111.06 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 31.75% vs 54.45% in Mar 2023

Profit And Loss - Interest
Interest 16.74 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is -49.14% vs -1.66% in Mar 2023

Profit And Loss - Profit After Tax
Profit After Tax 95.06 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 72.07% vs 197.10% in Mar 2023